Reference : 3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell i...
Scientific journals : Article
Human health sciences : Oncology
http://hdl.handle.net/2268/12351
3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo
English
Kempen, I. [ > > ]
Papapostolou, D. [> > > >]
Thierry, N. [> > > >]
Pochet, L. [> > > >]
Counerotte, Stéphane mailto [Université de Liège - ULg > > Chimie pharmaceutique >]
Masereel, B. [> > > >]
Foidart, Jean-Michel mailto [Université de Liège - ULg > Département des sciences cliniques > Gynécologie - Obstétrique >]
Reboud-Ravaux, M. [> > > >]
Noël, Agnès mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme >]
Pirotte, Bernard mailto [Université de Liège - ULg > > Chimie pharmaceutique >]
7-Apr-2003
British Journal of Cancer
Nature Publishing Group
88
7
1111-1118
Yes (verified by ORBi)
International
0007-0920
1532-1827
London
United Kingdom
[en] coumarin derivatives ; cell invasion ; tumour growth
[en] In search for new anticancer agents, we have evaluated the antiinvasive and antimigrative properties of recently developed synthetic coumarin derivatives among which two compounds revealed important activity: 3-chlorophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate and 3-bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate, Both drugs were able to inhibit cell invasion markedly in a Boyden chamber assay, the bromo derivative being more potent than the reference matrix metalloprotease (MMP) inhibitor GI 129471. In vivo, tumour growth was reduced when nude mice grafted with HT 1080 or MDA-MB231 cells were treated i.p. 3 days week(-1) with the bromo coumarin derivative. These effects were not associated with the inhibition of urokinase, plasmin, MMP-2 or MMP-9. The mechanism of action of the drugs remains to be elucidated. However, these two coumarin derivatives may serve as new lead compounds of an original class of antitumour agents.
http://hdl.handle.net/2268/12351
10.1038/sj.bjc.6600856

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Kempen I BJC 2003.pdf.pdfAuthor postprint541.23 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.